126 related articles for article (PubMed ID: 2513137)
1. Effect of the irreversible aromatase inhibitor FCE 24304 on DMBA-induced mammary tumors in ovariectomized rats treated with testosterone.
Zaccheo T; Di Salle E
Cancer Chemother Pharmacol; 1989; 25(2):95-8. PubMed ID: 2513137
[TBL] [Abstract][Full Text] [Related]
2. Antitumor activity of the aromatase inhibitor FCE 24928 on DMBA-induced mammary tumors in ovariectomized rats treated with testosterone.
Zaccheo T; di Salle E
Cancer Chemother Pharmacol; 1993; 31(4):308-12. PubMed ID: 8422695
[TBL] [Abstract][Full Text] [Related]
3. A new irreversible aromatase inhibitor, 6-methylenandrosta-1,4-diene-3,17-dione (FCE 24304): antitumor activity and endocrine effects in rats with DMBA-induced mammary tumors.
Zaccheo T; Giudici D; Lombardi P; di Salle E
Cancer Chemother Pharmacol; 1989; 23(1):47-50. PubMed ID: 2491793
[TBL] [Abstract][Full Text] [Related]
4. Antitumor effect of pyridoglutethimide, an aromatase inhibitor, on 7,12-dimethylbenz(a)anthracene-induced mammary tumors of rat.
Yamamoto T; Urabe M; Tamura T; Kitawaki J; Honjo H; Okada H
Anticancer Res; 1991; 11(6):1999-2002. PubMed ID: 1776832
[TBL] [Abstract][Full Text] [Related]
5. Aromatase inhibition and experimental antitumor activity of FCE 24304, MDL 18962 and SH 489.
di Salle E; Briatico G; Giudici D; Ornati G; Zaccheo T
J Steroid Biochem; 1989; 34(1-6):431-4. PubMed ID: 2516584
[TBL] [Abstract][Full Text] [Related]
6. Inhibitory effect of combined treatment with the aromatase inhibitor exemestane and tamoxifen on DMBA-induced mammary tumors in rats.
Zaccheo T; Giudici D; Di Salle E
J Steroid Biochem Mol Biol; 1993 Mar; 44(4-6):677-80. PubMed ID: 8476783
[TBL] [Abstract][Full Text] [Related]
7. Comparison of the effects of the irreversible aromatase inhibitor exemestane with atamestane and MDL 18962 in rats with DMBA-induced mammary tumours.
Zaccheo T; Giudici D; Ornati G; Panzeri A; di Salle E
Eur J Cancer; 1991; 27(9):1145-50. PubMed ID: 1835626
[TBL] [Abstract][Full Text] [Related]
8. Antitumor effect of a specific aromatase inhibitor, 1-methyl-androsta-1,4-diene-3,17-dione (atamestane), in female rats bearing DMBA-induced mammary tumors.
Nishino Y; Schneider MR; Michna H; el Etreby MF
J Steroid Biochem; 1989; 34(1-6):435-7. PubMed ID: 2533949
[TBL] [Abstract][Full Text] [Related]
9. Combined and sequential treatment using FCE 21336, a new prolactin-lowering drug, and medroxyprogesterone acetate (MPA) in DMBA-induced tumors in rats.
Zaccheo T; Casazza AM; di Salle E; Pollini C; di Marco A
Eur J Cancer Clin Oncol; 1984 Sep; 20(9):1193-7. PubMed ID: 6236980
[TBL] [Abstract][Full Text] [Related]
10. Potent inhibitory effect of a new antiestrogen (RU 16117) on the growth of 7,12-dimethylbenz[a]anthracene-induced rat mammary tumors.
Kelly PA; Asselin J; Caron MG; Labrie F; Raynaud JP
J Natl Cancer Inst; 1977 Mar; 58(3):623-8. PubMed ID: 402479
[TBL] [Abstract][Full Text] [Related]
11. Antitumoral and endocrine effects of (+)-vorozole in rats bearing dimethylbenzanthracene-induced mammary tumors.
De Coster R; Van Ginckel RF; Callens MJ; Goeminne NK; Janssens BL
Cancer Res; 1992 Mar; 52(5):1240-4. PubMed ID: 1737385
[TBL] [Abstract][Full Text] [Related]
12. Antiproliferative effect of the new aromatase inhibitor fadrozole on pre- and postmenopausal models of rat mammary tumor.
Tanaka M; Yano S; Hasegawa Y; Nakao K
Arzneimittelforschung; 1994 Jun; 44(6):774-8. PubMed ID: 8053980
[TBL] [Abstract][Full Text] [Related]
13. Effects of combined and sequential treatment with tamoxifen and the aromatase inhibitor vorozole on 7,12-dimethylbenz(a) anthracene-induced mammary carcinoma in the rat.
Van Ginckel R; Janssens B; Callens M; Goeminne N; Wouters L; De Coster R
Cancer Chemother Pharmacol; 1996; 38(1):21-8. PubMed ID: 8603447
[TBL] [Abstract][Full Text] [Related]
14. Antitumor effects of SEF19, a new nonsteroidal aromatase inhibitor, on 7,12-dimethylbenz[a]anthracene-induced mammary tumors in rats.
Iino Y; Karakida T; Sugamata N; Andoh T; Takei H; Takahashi M; Yaguchi S; Matsuno T; Takehara M; Sakato M; Kawashima S; Morishita Y
Anticancer Res; 1998; 18(1A):171-6. PubMed ID: 9568073
[TBL] [Abstract][Full Text] [Related]
15. A new aromatase inhibitor, FR901537. II. Pharmacological and antitumor effects.
Oohata N; Kawamura I; Lacey E; Nishigaki F; Matsumoto S; Tsujimoto S; Naoe Y; Manda T; Shimomura K
J Antibiot (Tokyo); 1995 Aug; 48(8):763-7. PubMed ID: 7592018
[TBL] [Abstract][Full Text] [Related]
16. Melatonin inhibits the growth of DMBA-induced mammary tumors by decreasing the local biosynthesis of estrogens through the modulation of aromatase activity.
Cos S; González A; Güezmes A; Mediavilla MD; Martínez-Campa C; Alonso-González C; Sánchez-Barceló EJ
Int J Cancer; 2006 Jan; 118(2):274-8. PubMed ID: 16080194
[TBL] [Abstract][Full Text] [Related]
17. 4-Aminoandrostenedione derivatives: a novel class of irreversible aromatase inhibitors. Comparison with FCE 24304 and 4-hydroxyandrostenedione.
Di Salle E; Giudici D; Ornati G; Briatico G; D'Alessio R; Villa V; Lombardi P
J Steroid Biochem Mol Biol; 1990 Nov; 37(3):369-74. PubMed ID: 2257240
[TBL] [Abstract][Full Text] [Related]
18. Effects of the aromatase inhibitor 7 alpha-(4'-amino)phenylthio-4-androstene-3,17-dione on 7,12-dimethylbenz(a)anthracene-induced mammary carcinoma in rats.
Brueggemeier RW; Li PK
Cancer Res; 1988 Dec; 48(23):6808-10. PubMed ID: 3141048
[TBL] [Abstract][Full Text] [Related]
19. The effect of the aromatase inhibitor, 4-(phenylthio)-4-androstene-3,17-dione, on dimethylbenz(A)anthracene-induced rat mammary tumors.
Abul-Hajj YJ
J Steroid Biochem; 1989; 34(1-6):439-42. PubMed ID: 2516585
[TBL] [Abstract][Full Text] [Related]
20. Effect of wheat bran fiber on the development of mammary tumors in female intact and ovariectomized rats treated with 7,12-dimethylbenz(a)anthracene and in mice with spontaneously developing mammary tumors.
Zile MH; Welsch CW; Welsch MA
Int J Cancer; 1998 Jan; 75(3):439-43. PubMed ID: 9455806
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]